APOE and Alzheimer disease: As expected, MCI-AD patients presented with a more severe cognitive impairment at baseline (significantly lower MMSE and MoCA and higher ADAS-Cog scores) than MCI-St patients, and were also more frequently APOE-ε4 carriers.